Forecast & Rating2 analysts currently cover Cocrystal Pharma, of which 1 give a positive rating. The average price target is $9.00, about 625.8% upside from the current price of $1.24. Coverage is limited, so the data is for reference only. Data as of Aug 20, 2026; this does not constitute investment advice.
Aug 20, 2026Price forecast
$9.00625.81%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 7, 2026
Forecast met0.0%
Stock price$1.24
Avg. target$8.0
High target$10
Low target$6
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.